Sign up
Pharma Capital

Genes2me diagnostic test commercially available in India

Genes2me LLP CEO & Founder Neeraj Gupta sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Genes2me is an India-based high end diagnostic lab.

 

View full GENE2 profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.